LIGAND PHARMACEUTICALS INCORPORATED Income (Loss) from Continuing Operations, Per Basic and Diluted Share
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Income (Loss) from Continuing Operations, Per Basic and Diluted Share of $0.13 per share for the 3-month period ending 2013-12-31, per its 10-K filed 2014-12-01.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare · last filed 2014-12-12
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations, per basic and diluted share for the quarter ending 2013-12-31 was $0.13, a 0.00% change year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations, per basic and diluted share for the quarter ending 2013-09-30 was -$0.01.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations, per basic and diluted share for the quarter ending 2013-06-30 was -$0.22.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations, per basic and diluted share for the quarter ending 2013-03-31 was -$0.04.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations, per basic and diluted share for fiscal 2012 was -$0.13, a 126.53% decline from fiscal 2011.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations, per basic and diluted share for fiscal 2011 was $0.49.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations, per basic and diluted share for fiscal 2010 was -$0.65.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations, per basic and diluted share for fiscal 2009 was -$0.44.
| Period end | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 9 month as first filed | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 12 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2013-12-31 | $0.13 10-K · filed 2014-12-01 | |||||||
| 2013-09-30 | -$0.01 10-K · filed 2014-12-01 | |||||||
| 2013-06-30 | -$0.22 10-K · filed 2014-12-01 | |||||||
| 2013-03-31 | -$0.04 10-K · filed 2014-12-01 | $0.06 10-Q · filed 2013-05-08 | ||||||
| 2012-12-31 | $0.13 10-K/A · filed 2014-12-12 | -$0.13 10-K · filed 2013-03-14 | ||||||
| 2012-09-30 | -$0.01 10-K/A · filed 2014-12-12 | -$0.27 10-Q · filed 2012-11-14 | ||||||
| 2012-06-30 | -$0.22 10-K/A · filed 2014-12-12 | -$0.20 10-Q · filed 2012-08-08 | -$0.26 10-Q/A · filed 2012-11-14 | -$0.23 10-Q · filed 2012-08-08 | ||||
| 2012-03-31 | -$0.04 10-K/A · filed 2014-12-12 | -$0.03 10-Q · filed 2012-05-04 | ||||||
| 2011-12-31 | $0.24 10-K · filed 2013-03-14 | $0.49 10-K · filed 2013-03-14 | $0.52 10-K · filed 2012-02-23 | |||||
| 2011-09-30 | -$0.21 10-K · filed 2013-03-14 | -$0.20 10-Q · filed 2011-11-08 | $0.26 10-Q · filed 2012-11-14 | $0.24 10-Q · filed 2011-11-08 | ||||
| 2011-06-30 | -$0.02 10-K · filed 2013-03-14 | -$0.05 10-Q · filed 2011-08-08 | $0.47 10-Q/A · filed 2012-11-14 | $0.44 10-Q · filed 2011-08-08 | ||||
| 2011-03-31 | $0.49 10-K · filed 2013-03-14 | $0.51 10-Q · filed 2012-05-04 | ||||||
| 2010-12-31 | -$0.65 10-K · filed 2013-03-14 | |||||||
| 2010-09-30 | -$0.60 10-Q/A · filed 2012-02-10 | -$0.77 10-Q/A · filed 2012-02-10 | ||||||
| 2010-06-30 | -$0.01 10-Q/A · filed 2012-02-10 | -$0.16 10-Q/A · filed 2012-02-10 | ||||||
| 2009-12-31 | -$0.44 10-K/A · filed 2012-11-14 |